The Moderna Vaccine IndexThese companies are selected for composition "Moderna Vaccine" because
1.developed the vaccine
2.suppliers
3.distribution chain
Weights are calculated by relative market cap.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
158.29 M CHF
770.84 M CHF
18.30 M
About LABORATORIOS FARMACEUTICOS ROVI S.A.
Sector
CEO
Juan López-Belmonte Encina
Headquarters
Madrid
Website
Founded
1946
ISIN
ES0157261019
FIGI
BBG00LVDP609
Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 41L is 85.182 CHF — it has increased by 6.41% in the past 24 hours. Watch LABORAT FARMA ROVI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange LABORAT FARMA ROVI stocks are traded under the ticker 41L.
41L stock hasn't changed in a week, the last month showed zero change in price, over the last year LABORAT FARMA ROVI has showed a 103.22% increase.
We've gathered analysts' opinions on LABORAT FARMA ROVI future price: according to them, 41L price has a max estimate of 94.27 CHF and a min estimate of 80.51 CHF. Watch 41L chart and read a more detailed LABORAT FARMA ROVI stock forecast: see what analysts think of LABORAT FARMA ROVI and suggest that you do with its stocks.
41L stock is 6.02% volatile and has beta coefficient of 0.67. Track LABORAT FARMA ROVI stock price on the chart and check out the list of the most volatile stocks — is LABORAT FARMA ROVI there?
Today LABORAT FARMA ROVI has the market capitalization of 3.10 B, it has increased by 0.96% over the last week.
Yes, you can track LABORAT FARMA ROVI financials in yearly and quarterly reports right on TradingView.
LABORAT FARMA ROVI is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
41L net income for the last quarter is 65.24 M CHF, while the quarter before that showed 47.87 M CHF of net income which accounts for 36.30% change. Track more LABORAT FARMA ROVI financial stats to get the full picture.
Yes, 41L dividends are paid annually. The last dividend per share was 0.87 CHF. As of today, Dividend Yield (TTM)% is 1.37%. Tracking LABORAT FARMA ROVI dividends might help you take more informed decisions.
LABORAT FARMA ROVI dividend yield was 1.49% in 2023, and payout ratio reached 27.20%. The year before the numbers were 2.91% and 28.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 16, 2024, the company has 2.11 K employees. See our rating of the largest employees — is LABORAT FARMA ROVI on this list?
Like other stocks, 41L shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LABORAT FARMA ROVI stock right from TradingView charts — choose your broker and connect to your account.